An international team of physicians and scientists in Florida have discovered a way to treat cardiomyopathy (heart disease) with adult stem cells, including a rare metabolic condition otherwise requiring heart transplant.
Regenocyte Therapeutic is using stem cells extracted from patients’ blood to repair damaged heart muscle, regenerate tissue, and create new vessels to improve circulation. According to the organization’s director of Cardiology and Vascular Disease, Zannos G. Grekos, M.D., by applying specific growth factors to the patient’s stem cells the team creates a new cell population which is educated to target the area of damage or deficiency when placed into
Stem Cell Research and Therapy for Cardiomyopathy
Adult Stem Cell research has performed another miracle and it is fitting that it is a Reverend who has been helped this time for his dilated cardiomyopathy and congestive heart failure. Reverend Dan Jackson, of Colorado has reported that his ejection fraction has more than doubled after a […]
Howie Lindeman was facing the loss of his career and Neim Malo wasn’t supposed to see 2011. They were each treated for heart disease years ago using their own stem cells to repair their damaged heart tissue. Several years following treatment, both men continue to see improvement in their condition and quality of life.
Howie Lindeman, 60, had a heart attack at 39 years old that severely damaged his heart. He went through several procedures including having stents placed in his arteries and his physicians were considering open heart surgery for a quintuple bypass. He was in constant pain and
Last year, Japanese researchers announced that the first human patient would be treated with induced pluripotent stem cells in an attempt to reverse a degenerative eye condition called macular degeneration that leads to vision loss.
Now, a team of scientists headed by biologists at UC San Diego has discovered how induced pluripotent stem (iPS) cells, which are derived from an individual’s own cells, could be programmed to avoid rejection from the immune system.
Their findings, published online ahead of print in the journal Cell Stem Cell, show that iPS cells can differentiate or change into various types of functional cells with
Image via Wikipedia
As former House speaker Newt Gingrich courts evangelical voters in advance of Tuesday’s Florida primary, he is drawing an increasingly hard line against the use of embryonic stem-cell research — a position that contrasts not only with that of former Massachusetts governor Mitt Romney, but also with statements that Gingrich himself has made on the subject in the past.
Speaking at a Baptist church in Winter Park on Saturday, the former speaker received a standing ovation when he declared that embryonic stem-cell research amounts to “the use of science to desensitize society over the killing of babies.”